David W. Anderson

Person

West Chester, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Gene therapies for neurodegenerative disorders targeting gangliosid...
- Patent number 10,874,749
- Issue date Dec 29, 2020
- Thomas Jefferson University
- Jay S. Schneider
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
SECRETABLE PROTEIN INDUCED IMMUNE TOLERIZATION AND TREATMENT OF AUT...
- Publication number 20230040275
- Publication date Feb 9, 2023
- Spark Therapeutics, Inc.
- David William ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AAV VECTOR TREATMENT METHODS FOR LATE INFANTILE NEURONAL CEROID LIP...
- Publication number 20220184188
- Publication date Jun 16, 2022
- Spark Therapeutics, Inc.
- David William ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE THERAPIES FOR NEURODEGENERATIVE DISORDERS TARGETING GANGLIOSID...
- Publication number 20210213142
- Publication date Jul 15, 2021
- Thomas Jefferson University
- Jay S. Schneider
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
GENE THERAPIES FOR NEURODEGENERATIVE DISORDERS TARGETING GANGLIOSID...
- Publication number 20180214573
- Publication date Aug 2, 2018
- Thomas Jefferson University
- David W. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ganglioside Transmucosal Formulations
- Publication number 20160082026
- Publication date Mar 24, 2016
- LZ Therapeutics, Inc.
- Jay S. Schneider
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ganglioside Transmucosal Formulations
- Publication number 20150283158
- Publication date Oct 8, 2015
- LZ Therapeutics, Inc.
- John J. Koleng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Glaucoma and Other Retinopathies with Gangliosides
- Publication number 20140309179
- Publication date Oct 16, 2014
- LZ Therapeutics, Inc.
- Jay S. Schneider
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ganglioside Transmucosal Formulations
- Publication number 20120220544
- Publication date Aug 30, 2012
- Jay S. Schneider
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Glaucoma and Other Retinopathies with Gangliosides
- Publication number 20120220543
- Publication date Aug 30, 2012
- Jay S. Schneider
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

David W. Anderson

Person

Patents Grantslast 30 patents

Gene therapies for neurodegenerative disorders targeting gangliosid...

Patents Applicationslast 30 patents

SECRETABLE PROTEIN INDUCED IMMUNE TOLERIZATION AND TREATMENT OF AUT...

AAV VECTOR TREATMENT METHODS FOR LATE INFANTILE NEURONAL CEROID LIP...

GENE THERAPIES FOR NEURODEGENERATIVE DISORDERS TARGETING GANGLIOSID...

GENE THERAPIES FOR NEURODEGENERATIVE DISORDERS TARGETING GANGLIOSID...

Ganglioside Transmucosal Formulations

Ganglioside Transmucosal Formulations

Treatment of Glaucoma and Other Retinopathies with Gangliosides

Ganglioside Transmucosal Formulations

Treatment of Glaucoma and Other Retinopathies with Gangliosides